Life settlements represent one of the primary access points for investors seeking exposure to longevity markets. These investments have been impacted by longevity extension in the form of changing mortality patterns. Since the time this market attracted institutional capital, several changes to reference mortality tables have negatively impacted expected financial performance.
Extropy Capital is positioned to adapt past experience, harnessing accumulated data and research to refine investment metrics for efficient capital deployment up and down the spectrum of life-based assets and structured products.
Extropy Capital brings a forward thinking and innovative discipline to the longevity linked asset space. Our investment methodology is the result of a combined fifty years experience in all facets of longevity markets.